Skip to main content
Back
Activeted-512862-2026

Pharmaceuticals with active ingredient Entecavir in film-coated tablet form

Discount agreements for finished pharmaceuticals with the active ingredient Entecavir (film-coated tablets): Conclusion of non-exclusive contracts under an open-house model according to § 130a para. 8 SGB V. Contract conclusion is possible at any time under the same conditions with any qualified pharmaceutical company; no individual negotiations. The earliest contract start date is 01.10.2026, with a maximum contract duration of 24 months, ending on 30.09.2028. Contracts may be terminated if exclusive contracts for the active ingredients are tendered. This is not a public contract award according to § 103 GWB.

View original source

CONTRACTING AUTHORITY

Name

AOK Sachsen - Anhalt

City

Magdeburg

Country

DE

CLASSIFICATION

Procedure Type

Open Procedure

Contract Type

Supplies

Main CPV

33600000, Pharmaceutical products.

ADDITIONAL DETAILS

EU Funded

Yes

Suitable for SMEs

No

Electronic Submission

not-allowed

Legal Basis

32014L0024

DEADLINES & TIMELINE

Submission Deadline

738 days remaining

(LOT-0001)

Published

TENDER DOCUMENTS

738 days remaining

Similar Tenders

Explore CPV 33

Medicinal products with the active ingredient Somatropin

Conclusion of non-exclusive rebate agreements according to § 130a Abs. 8 SGB V for finished medicinal products containing the active ingredient Somatropin (ATC: H01AC01): Contracts are concluded under an open-house model with every eligible pharmaceutical company under the same conditions, without exclusivity or individual negotiations. The earliest contract start date is September 1, 2026, with a maximum contract duration of 24 months, ending on August 31, 2028. This publication does not constitute a public contract within the meaning of § 103 GWB and serves for transparency.

AOK Sachsen - Anhalt

·Magdeburg
Deadline:June 29, 2028

Medicinal products with the active ingredient Alitretinoin

Discount agreements for finished medicinal products with the active ingredient Alitretinoin (ATC: D11AH04): Conclusion of non-exclusive contracts under an open-house model with every eligible pharmaceutical company. No exclusivity, no individual contract negotiations. Earliest contract start is 01.09.2026, maximum duration 24 months, contract ends on 31.08.2028. Contracts may be terminated prematurely if AOK Sachsen-Anhalt tenders exclusive contracts for the active ingredients. This is not a public contract according to § 103 GWB.

AOK Sachsen - Anhalt

·Magdeburg
Deadline:June 29, 2028

Medicinal products with Brivaracetam

Discount agreements for finished medicinal products containing Brivaracetam: non-exclusive contracts according to § 130a Abs. 8 SGB V under an open-house model; conclusion possible at any time with any qualified pharmaceutical company; earliest contract start 01.09.2026, maximum duration 24 months, contract ends 31.08.2028. This is not a public contract within the meaning of § 103 GWB.

AOK Sachsen - Anhalt

·Magdeburg
Deadline:June 29, 2028

Discount Agreements for Pharmaceuticals with Midazolam

Discount agreements for finished pharmaceuticals containing the active ingredient Midazolam (ATC: N03AE02): Conclusion of non-exclusive contracts according to § 130a Abs. 8 SGB V within an open-house model. Contract conclusion is possible at any time under the same conditions for all eligible pharmaceutical companies, without individual contract negotiations. The earliest contract start date is September 1, 2026, with a maximum duration of 24 months; the contract ends no later than August 31, 2028. Contracts may be terminated prematurely if AOK Sachsen-Anhalt tenders exclusive contracts for the active ingredients. This does not constitute the award of a public contract within the meaning of § 103 GWB.

AOK Sachsen - Anhalt

·Magdeburg
Deadline:June 29, 2028

Find matching tenders automatically

With Patterno-HIT, receive relevant tenders daily, automatically filtered to your company profile.

Book Demo Now